Literature

Publications

1. Dohnal, A. M., R. Luger, P. Paul, D. Fuchs, and T. Felzmann. 2009.
   CD40 ligation restores type 1 polarizing capacity in TLR4-activated dendritic cells that have ceased interleukin-12 expression.
   J Cell Mol Med 13:1741-1750.
2. Dohnal, A. M., S. Graffi, V. Witt, C. Eichstill, D. Wagner, S. Ul-Haq, D. Wimmer, and T. Felzmann. 2009.
   Comparative evaluation of techniques for the manufacturing of dendritic cell-based cancer vaccines.
   J Cell Mol Med 13:125-135.
3. Dohnal, A. M., V. Witt, H. Hugel, W. Holter, H. Gadner, and T. Felzmann. 2007.
   Phase I study of tumor Ag-loaded IL-12 secreting semi-mature DC for the treatment of pediatric cancer.
   Cytotherapy 9:755-770.
4. Wimpissinger, T. F., T. Felzmann, H. Hügel, P. Funovics, and W. Stackl. 2006.
   Treatment of advanced renal cell carcinoma with tumor lysate pulsed IL-12 secreting autologous dendritic cells.
   J Clin Oncol 24:14585.
5. Hüttner, K. G., S. K. Breuer, P. Paul, O. Majdic, A. Heitger, and T. Felzmann. 2005.
   Generation of potent anti-tumor immunity in mice by interleukin-12-secreting dendritic cells.
   Cancer Immunol Immunother 54:67-77.
6. Felzmann, T., K. G. Huttner, S. K. Breuer, D. Wimmer, G. Ressmann, D. Wagner, P. Paul, M. Lehner, A. Heitger, and W. Holter. 2005.
   Semi-mature IL-12 secreting dendritic cells present exogenous antigen to trigger cytolytic immune responses.
   Cancer Immunol Immunother 54:769-780.